Effects of Preoperative Fasting on ECG and Vital Parameters

October 17, 2016 updated by: Bozyaka Training and Research Hospital

Effects of Preoperative Fasting on ECG and Vital Parameters in Patients Undergoing Orthopedic and Urologic Surgery

This study compares differences in hemodynamic ve ECG parameters of patients undergoing urological or orthopedic surgery under spinal anesthesia. First group will comprise of patients undergoing surgery in the morning hours; thus with a standard fasting duration (8 hours), and the second group will comprise of patients undergoing surgery afternoon; thus having a prolonged fasting duration (>12 hours).

Study Overview

Detailed Description

Patients who are scheduled for surgery in surgical wards are routinely fasted after 12am on the day of the surgery regardless of the planned hour of the surgery. This results in a near standard fasting for patients with a planned surgery time in morning hours of the day. However, patients with a planned surgery time in the afternoon hours of the day are fasted more than 12 hours. This situation may not look very important for a healthy young adult but considering that the patient population in a hospital is mostly consisted of sick and elderly people, fasting and associated dehydration may have serious deleterious effects. Our objective is to observe and define these potential deleterious effects with a special focus on cardiovascular system of the patients.

Study Type

Observational

Enrollment (Actual)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Izmir, Turkey, 35170
        • Izmir Bozyaka Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients over the age of 60 who scheduled for urological or orthopedic surgery under spinal anesthesia

Description

Inclusion Criteria:

  • Patients over 60 years of age
  • Patients with an ASA (American Society of Anesthesiologists) physical status score of 1, 2 or 3
  • Patients scheduled for elective orthopedic or urological surgery under spinal anesthesia

Exclusion Criteria:

  • Patients requiring emergency surgery
  • Patients under 60 years of age
  • Rejecting to participate in the study
  • Contraindications to spinal anesthesia
  • Evidence of myocardial ischemia in baseline electrocardiogram prior to surgery
  • Conditions mimicking electrocardiographic signs of myocardial ischemia (e.g. electrolyte imbalances such as hypokalemia)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Cohort 1- Morning Surgery
Patients' who are scheduled for surgery under spinal anesthesia with bupivacaine in morning hours (until 12pm) will be included in this cohort. Since all patients are ordered to stop oral ingestion by 12am at the day of the surgery, patients in this cohort will be exposed to a preoperative fasting for 8 hours
Patients will be exposed to preoperative fasting
Other Names:
  • Shorter Fasting
Spinal Anesthesia with heavy bupivacaine 0.5% is provided.
Other Names:
  • Spinal Block
Cohort 2- Afternoon Surgery
Patients' who are scheduled for surgery under spinal anesthesia with bupivacaine in afternoon hours (after 12pm) will be included in this cohort. Since all patients are ordered to stop oral ingestion by 12am at the day of the surgery, patients in this cohort will be exposed to a preoperative fasting for more than 12 hours
Spinal Anesthesia with heavy bupivacaine 0.5% is provided.
Other Names:
  • Spinal Block
Patients will be exposed to preoperative fasting
Other Names:
  • Longer Fasting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evidence of ischemic changes in 12 lead electrocardiogram
Time Frame: Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Changes in ST and T waves compared to a baseline preoperative ECG will be monitored and recorded right after spinal block is placed, and at 1st, 2nd, 5th and 15th minutes after spinal injection
Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Evidence of hypotension confirmed by non-invasive blood pressure measurement
Time Frame: Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Changes in mean arterial blood pressure will be monitored and a decrease of 10% from baseline mean arterial blood pressure will be recorded as hypotension right after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block spinal block is placed
Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Evidence of hypertension confirmed by non-invasive blood pressure measurement
Time Frame: Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Changes in mean arterial blood pressure will be monitored and an increase of 10% from baseline mean arterial blood pressure will be recorded as hypertension right after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Evidence of hypoxia confirmed by peripheral oxygen saturation probe
Time Frame: Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Peripheral oxygen saturation will be continuously monitored and any value less than 90% will be recorded right after spinal block is placed, at first, second, fifth minutes and at 15th minute
Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Evidence of tachycardia in 12 lead electrocardiogram
Time Frame: Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
A heart rate equal to / higher than 100 will be recorded right after spinal block is placed, at first, second, fifth minutes and again at 15th minute
Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
Evidence of bradycardia in 12-lead electrocardiogram
Time Frame: Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block
A heart rate equal to / less than 50 will be recorded right after spinal block is placed, at first, second, fifth minutes and again at 15th minute
Immediately after, 1, 2, 5 and 15 minutes after injection of bupivacaine for spinal block

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Oguzhan Yeniay, MD, Izmir Bozyaka Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2016

Primary Completion (ACTUAL)

October 1, 2016

Study Completion (ACTUAL)

October 1, 2016

Study Registration Dates

First Submitted

May 11, 2016

First Submitted That Met QC Criteria

May 11, 2016

First Posted (ESTIMATE)

May 16, 2016

Study Record Updates

Last Update Posted (ESTIMATE)

October 18, 2016

Last Update Submitted That Met QC Criteria

October 17, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ischemia

Clinical Trials on Preoperative Fasting for 8 hours

3
Subscribe